Page last updated: 2024-09-04

docetaxel anhydrous and Carcinoma, Neuroendocrine

docetaxel anhydrous has been researched along with Carcinoma, Neuroendocrine in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (30.00)29.6817
2010's6 (60.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Batman, E; Cairns, DA; Cave, J; Chau, I; Craig, Z; Faluyi, O; Howard, H; Hubner, R; Lamarca, A; Mansoor, W; McNamara, MG; Meyer, T; Reed, N; Sarker, D; Sharma, R; Swain, J; Valle, JW; Wadsley, J; Wall, L1
Damhuis, RA; den Bakker, MA; Derks, JL; Dingemans, AC; Groen, HJ; Smit, EF; Speel, EM; Thunnissen, E; van den Broek, EC; van Suylen, RJ1
Enoki, Y; Fujimoto, S; Fukui, A; Morishita, H; Okuyama, Y; Yoshida, N1
Cortes Vizcaino, V; Gil Salom, M; Moratalla Charcos, LM; Osca Garcia, JM; Pastor Navarro, T1
Chang, C; Cui, Y; Hu, S; Jin, J; Li, L; Li, X; Luo, J; Sun, Y; Yeh, S1
Attar, HE; Belkheiri, S; Benchakroun, N; Benider, A; Bennani, Z; Bouchbika, Z; Jouhadi, H; Safini, F; Sahraoui, S; Tawfiq, N1
Goloubeva, O; Hussain, A; Khan, MA; Lee, D; Tang, Y; Wang, L1
Ahmadzadeh, A; Babaei, M; Elahi, F; Hassanpour, K; Yadollahzadeh, M1
Fujiwara, Y; Kunitoh, H; Nokihara, H; Ohe, Y; Sekine, I; Tamura, T; Tsuta, K; Yamada, K; Yamamoto, N1
Earl, S; Gounaris, I; Lyons, B; Rahamim, J; Shivasankar, S; Yiannakis, D1

Trials

1 trial(s) available for docetaxel anhydrous and Carcinoma, Neuroendocrine

ArticleYear
NET-02 trial protocol: a multicentre, randomised, parallel group, open-label, phase II, single-stage selection trial of liposomal irinotecan (nal-IRI) and 5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line therapy in patients with progressive
    BMJ open, 2020, 02-05, Volume: 10, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Clinical Trials, Phase II as Topic; Docetaxel; Fluorouracil; Humans; Irinotecan; Leucovorin; Multicenter Studies as Topic; Quality of Life; Randomized Controlled Trials as Topic

2020

Other Studies

9 other study(ies) available for docetaxel anhydrous and Carcinoma, Neuroendocrine

ArticleYear
Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter?
    The European respiratory journal, 2017, Volume: 49, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Docetaxel; Etoposide; Female; Gemcitabine; Humans; Male; Middle Aged; Netherlands; Paclitaxel; Pemetrexed; Registries; Small Cell Lung Carcinoma; Taxoids; Vinblastine; Vinorelbine

2017
A large cell neuroendocrine carcinoma of the gall bladder: diagnosis with 18FDG-PET/CT-guided biliary cytology and treatment with combined chemotherapy achieved a long-term stable condition.
    Japanese journal of clinical oncology, 2013, Volume: 43, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cisplatin; Disseminated Intravascular Coagulation; Docetaxel; Fatal Outcome; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Immunohistochemistry; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Taxoids; Tomography, X-Ray Computed; Treatment Failure

2013
Large-cell neuroendocrine carcinoma of prostate. Case report.
    Archivos espanoles de urologia, 2013, Volume: 66, Issue:4

    Topics: Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carboplatin; Carcinoma, Neuroendocrine; Combined Modality Therapy; Docetaxel; Fatal Outcome; Humans; Immunohistochemistry; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Taxoids

2013
Neuroendocrine prostate cancer (NEPCa) increased the neighboring PCa chemoresistance via altering the PTHrP/p38/Hsp27/androgen receptor (AR)/p21 signals.
    Oncogene, 2016, 11-24, Volume: 35, Issue:47

    Topics: Animals; Antineoplastic Agents; Carcinoma, Neuroendocrine; Cell Line, Tumor; Disease Models, Animal; Docetaxel; Drug Resistance, Neoplasm; HSP27 Heat-Shock Proteins; Humans; Male; p38 Mitogen-Activated Protein Kinases; Prostatic Neoplasms; Protein Kinase Inhibitors; Receptor, Parathyroid Hormone, Type 1; Receptors, Androgen; Signal Transduction; Taxoids; Xenograft Model Antitumor Assays

2016
[Primary large cell neuroendocrine carcinoma of the breast: a rare tumor in humans].
    The Pan African medical journal, 2016, Volume: 25

    Topics: Antineoplastic Agents; Breast Neoplasms, Male; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Docetaxel; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pleural Neoplasms; Tamoxifen; Taxoids; Treatment Outcome

2016
The relationship of neuroendocrine carcinomas to anti-tumor therapies in TRAMP mice.
    The Prostate, 2009, Dec-01, Volume: 69, Issue:16

    Topics: Adenocarcinoma; Androgen Antagonists; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Carcinoma, Neuroendocrine; Cell Proliferation; Docetaxel; Drug Therapy, Combination; Incidence; Male; Mice; Mice, Transgenic; Neoplasm Proteins; Prostatic Neoplasms; Survival Analysis; Taxoids

2009
Neuroendocrine tumor of the gallbladder.
    Archives of Iranian medicine, 2013, Volume: 16, Issue:2

    Topics: Antineoplastic Agents; Carcinoma, Neuroendocrine; Catheter Ablation; Cisplatin; Deoxycytidine; Docetaxel; Drug Therapy, Combination; Female; Gallbladder; Gallbladder Neoplasms; Gemcitabine; Humans; Indoles; Middle Aged; Pyrroles; Sunitinib; Taxoids; Ultrasonography

2013
Effect of platinum combined with irinotecan or paclitaxel against large cell neuroendocrine carcinoma of the lung.
    Japanese journal of clinical oncology, 2007, Volume: 37, Issue:7

    Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cisplatin; Docetaxel; Etoposide; Female; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Retrospective Studies; Taxoids; Vinblastine; Vinorelbine

2007
Marked response to a cisplatin/docetaxel/temozolomide combination in a heavily pretreated patient with metastatic large cell neuroendocrine lung carcinoma.
    Anti-cancer drugs, 2007, Volume: 18, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cisplatin; Dacarbazine; Docetaxel; Fatal Outcome; Female; Humans; Lung Neoplasms; Middle Aged; Quality of Life; Taxoids; Temozolomide

2007
chemdatabank.com